Moderna, Inc. — Director's Dealing 2020

Mar 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-03-17

Reporting Person: Andres Juan (See remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-17	Common Stock	M	16317	$12.21	Acquired	16317	Direct
2020-03-17	Common Stock	S	10006	$30.47	Disposed	6311	Direct
2020-03-17	Common Stock	S	5581	$31.98	Disposed	730	Direct
2020-03-17	Common Stock	S	730	$32.50	Disposed	0	Direct
2020-03-18	Common Stock	M	15281	$12.21	Acquired	15281	Direct
2020-03-18	Common Stock	S	7094	$31.06	Disposed	8187	Direct
2020-03-18	Common Stock	S	8187	$31.75	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-17	Stock Option (Right to Buy)	$12.21	M	16317	Disposed	2027-08-29	Common Stock (16317)	Direct
2020-03-18	Stock Option (Right to Buy)	$12.21	M	15281	Disposed	2027-08-29	Common Stock (15281)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.05 to $30.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.40 to $32.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.42 to $32.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.40 to $31.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.43 to $32.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: 25% of this option vested and became exercisable on August 1, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.